首页> 中文期刊>中外医学研究 >血清脂肪酶联合血清红细胞压积评估急性重症胰腺炎的价值

血清脂肪酶联合血清红细胞压积评估急性重症胰腺炎的价值

     

摘要

Objective:To investigate the value of serum lipase(LPS) and hematocrit(HCT) level as early markers in severe acute pancreatitis(SAP). Method:Serum HCT and LPS within 24 hours after admission in hospitalized patients with severe acute pancreatitis were analyzed and compared with MAP group and the control group.The value within 24 h HCT,LPS changes associated with acute pancreatitis severity and early predictive value for severe pancreatitis was evaluated.Result:LPS in SAP group was obviously higher than that in the MAP group and the control group,with significant difference(P<0.05).The level of HCT in SAP group was obviously higher than that in MAP group and the control group(P<0.05),while the HCT in MAP group and the control group had no statistically significant difference(P>0.05).Conclusion:Serum HCT combined with LPS can be used as indicators of early evaluation of SAP.%目的:探讨早期血清脂肪酶(LPS)及红细胞压积(HCT)在评估重症急性胰腺炎(SAP)中的临床价值。方法:分析因重症急性胰腺炎入院患者24 h内血清HCT及LPS水平,并与轻型急性胰腺炎(MAP)组及对照组比较,评价发病24 h内HCT、LPS的变化与急性胰腺炎轻重程度的关系及其对重症胰腺炎的早期预测价值。结果:SAP组中LPS水平明显高于轻型急性胰腺炎(MAP)组及对照组,差异均有统计学意义(P<0.05);SAP组血清HCT明显高于MAP组及对照组(P<0.05),而MAP组与对照组血清HCT相比差异无统计学意义(P>0.05)。结论:联合血清HCT与LPS可作为SAP的早期评估指标。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号